Cartesian Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
RNAC
CUSIP
816212302
Type
Equity
Class
COM NEW
Num filings
70
Total reported value, excl. options
$66.7 M
Manager Report Date Value ($000) Shares Option Type